Loading...
SANDOZ DO BRASIL IND FARMACEUTICA — Escitalopram Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #14 buyer for Escitalopram · $1.5M import value · 36 shipments · BRAZIL · DGFT Verified
SANDOZ DO BRASIL IND FARMACEUTICA is the #14 importer of Escitalopram from India with $1.5M in import value and 36 verified shipments. SANDOZ DO BRASIL IND FARMACEUTICA holds a 0.5% market share in Escitalopram imports based in BRAZIL. The company sources from 1 verified supplier across 22 formulations shipped to 1 country. Overall, SANDOZ DO BRASIL IND FARMACEUTICA imports 2 pharmaceutical products worth $2.0M across 1 therapeutic categories.
Verified from 36 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SANDOZ PRIVATE LIMITED | $1.5M | 36 | 100.0% |
SANDOZ DO BRASIL IND FARMACEUTICA sources Escitalopram from 1 verified Indian supplier based on 36 customs records. The primary supplier is SANDOZ PRIVATE LIMITED accounting for 100.0% of imports.
Destination countries from 36 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $1.5M | 36 | 100.0% |
SANDOZ DO BRASIL IND FARMACEUTICA imports Escitalopram to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $1.5M.
| Formulation | Value | Shipments |
|---|---|---|
| Material No. - 42030715, ESCITALOPRAM OX | $200.0K | 4 |
| MATERIAL NO-42030715 ESCITALOPRAM OXA FCT 20MG IN91 SH MSPCS | $149.2K | 3 |
| MATERIAL NO-42030721 ESCITALOPRAM OXA FCT 10MG IN91 SH MSPCS | $120.4K | 3 |
| Material No. - 42030721, ESCITALOPRAM OX | $100.0K | 2 |
| Material No-42030715, ESCITALOPRAM OXA F | $100.0K | 2 |
| Material No - 42030715, ESCITALOPRAM OXA | $100.0K | 2 |
| Material No 42030721 ESCITALOPRAM OXAFCT 10MG IN91 SH MS BATCH NO MV2415 MV2420 MV2417 MFG DATE 15 02 2023 DA | $100.0K | 2 |
| Material No.-42031184, ESCITALOPRAM OXA | $92.1K | 2 |
What SANDOZ DO BRASIL IND FARMACEUTICA and other importers must comply with to import Escitalopram from India
Brazilian Health Regulatory Agency (ANVISA)
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
India exported $33.3M worth of Escitalopram through 5,457 shipments from 231 suppliers to 95 countries, serving 628 buyers globally. SANDOZ DO BRASIL IND FARMACEUTICA imports $1.5M of this total, accounting for 0.5% of India's Escitalopram exports with 36 shipments from BRAZIL. This is verified from 36 customs shipment records covering 22 distinct formulations.
SANDOZ DO BRASIL IND FARMACEUTICA's average Escitalopram order value is $42.2K per consignment, based on 36 shipments totaling $1.5M. SANDOZ DO BRASIL IND FARMACEUTICA is based in BRAZIL and ranks #14 among all Escitalopram importers from India by value. The company sources from 1 verified supplier in India.
SANDOZ DO BRASIL IND FARMACEUTICA sources Escitalopram from 1 verified Indian supplier: SANDOZ PRIVATE LIMITED ($1.5M, 100.0%). This is based on 36 customs records.
SANDOZ DO BRASIL IND FARMACEUTICA ranks #14 among 628 Escitalopram importers from India with a 0.5% market share. The top 3 importers are TORRENT PHARMA INC ($4.2M), LEK S.A. ($4.1M), CIPLA MAROC ($3.5M). SANDOZ DO BRASIL IND FARMACEUTICA processed 36 shipments from BRAZIL.
SANDOZ DO BRASIL IND FARMACEUTICA also imports these cns & psychiatric products. Each links to the detailed product page.
SANDOZ DO BRASIL IND FARMACEUTICA imports 2 products worth $2.0M. Beyond Escitalopram, top products include Citalopram. View the complete SANDOZ DO BRASIL IND FARMACEUTICA profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Escitalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for SANDOZ DO BRASIL IND FARMACEUTICA's Escitalopram imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SANDOZ DO BRASIL IND FARMACEUTICA
Full Company Profile →
2 products · $2.0M total trade · 1 categories
| Material No.-42030721 ESCITALOPRAM OXA F |
| $50.0K |
| 1 |
| Material No 42030721 ESCITALOPRAM OXA | $50.0K | 1 |
SANDOZ DO BRASIL IND FARMACEUTICA imports 22 distinct Escitalopram formulations from India. The top formulation is Material No. - 42030715, ESCITALOPRAM OX with 4 shipments worth $200.0K.
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 95+ countries, 628+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for SANDOZ DO BRASIL IND FARMACEUTICA.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Escitalopram. For current order-level data, contact TransData Nexus.